Time-to-Market Record: Major EPCM Project in just 24 Months
ZETA accepted the challenge and successfully managed the project
In 2019, global pharmaceutical company Boehringer Ingelheim approached ZETA with a significant challenge. The goal was to implement a major EPCM project in just 24 months.
ZETA accepted the challenge and successfully managed the entire project – called G3Leopold – as a one-stop-shop for the customer. Everything was included: from the engineering of the entire plant, the process area, the architecture, and the technical building equipment, to the execution of the process plant, automation, commissioning, and qualification.
ZETA as a general planner
Boehringer Ingelheim commissioned ZETA with the general planning, construction supervision, and project management for all project phases of the entire facility, right through to commissioning. The planning, execution, and automation of the production process itself was in the hands of ZETA, and reliable partners were consulted in the sectors of construction, building services, and electrical engineering.
The top priority in the project: Time, time, time
Implementing “Ultra-Fast-Track” projects is an ongoing challenge that is addressed in ZETA biopharmaceutical projects. The complex G3 Leopold project broke time-to-market records: after groundbreaking on October 24th, 2019, the shell construction was completed at the beginning of April 2020, interior fittings and assembly followed by the end of September 2020, and commissioning in March 2021.
A project lead time of only 24 months for this major project? It was half the time that is usually allocated! ZETA accepted the challenge and took ownership of the tight timeline.
